📰 Named Patient Program News
Named Patient Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Named Patient Program. Real-time updates on events, politics, business and more.
December 30, 2023
ZURICH, SWITZERLAND / ACCESSWIRE / December 29, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system...
December 29, 2023
Zürich, Switzerland, December 29, 2023 - NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for...
July 17, 2023
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
January 9, 2023
HONG KONG, Jan. 9, 2023 /PRNewswire/ -- Luye Pharmas Innovative Anti-Cancer Therapy Lurbinectedin to Benefit
December 22, 2022
Investegate announcements from NLS Pharmaceutics AG, NLS Pharmaceutics Issues Letter to Shareholders
December 22, 2022
ZURICH, SWITZERELAND / ACCESSWIRE / December 22, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery
November 29, 2022
Medlab Clinical has announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for its lead product NanaBis (NanaDol in the UK) to be used under its
November 23, 2022
ZURICH, SWITZERLAND / ACCESSWIRE / November 23, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP), (NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery
November 23, 2022
Investegate announcements from NLS Pharmaceutics AG, NLS Pharmaceutics Announces Launch of Program
November 3, 2022
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...